Identifying expression and DNA methylation biomarkers for lung adenocarcinoma risk in East Asia
JNCI: Journal of the National Cancer Institute · 01.06.2026 · 118 (6) · 1032-1045
DOI: 10.1093/jnci/djag021 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, online erschienen am 24.01.2026. Verfasst von Tzu-Yu Chen und 30 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan. Hauptthemen laut MEDLINE: DNA Methylation, Lung Neoplasms, Adenocarcinoma, Biomarkers, Tumor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Health and Welfare grants, National Health Research Institutes, Ministry of Science and Technology.
Abstract (Originalsprache)
Background
Lung adenocarcinoma (LUAD) is the most common type of lung cancer. A recent genome-wide association study of lung adenocarcinoma in East Asia reported 28 independent susceptibility variants across 25 loci and identified 2 genes whose genetically predicted expression levels are associated with lung adenocarcinoma risk, using an ancestry-matched lung tissue expression quantitative trait loci (QTL) dataset. It is desirable to identify additional susceptibility loci and to understand their underlying biological mechanisms.
Methods
Using an expanded genome-wide association study of lung adenocarcinoma in East Asia and ancestry-matched lung tissue expression QTL and DNA methylation QTL datasets, we performed transcriptome-wide association studies and DNA methylome-wide association studies simultaneously and examined the association between measured expression of genes and DNA methylation of nearby CpGs. Genes and nearby CpGs are termed CpG–gene–LUAD trios if these 3 associations hold simultaneously.
Results
At a Bonferroni-corrected P value less than .05, we identified a new susceptibility locus (6p21.31; lead single-nucleotide polymorphism rs7772643), 10 lung adenocarcinoma–associated genes, and 86 lung adenocarcinoma–associated CpGs. At a false discovery rate q value less than 0.05, we identified 28 lung adenocarcinoma–associated genes, 220 lung adenocarcinoma–associated CpGs, and 45 CpG–gene–LUAD trios; among them, 43 were direction-matched regarding these 3 associations. These show that 23 of the known 28 susceptibility variants for lung adenocarcinoma in East Asia are near these genes or CpGs and MARCH3, ELF5, IKZF3, GSDMB, CCDC116, and DSP are putative novel candidate genes. Few of them were reported in lung adenocarcinoma in European populations.
Conclusions
This study substantially advances our understanding of the etiology of lung adenocarcinoma in East Asia and could be useful in developing translational applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan.
- Department of Smart Computing and Applied Mathematics, Tunghai University, Taichung, Taiwan.
- Department of Applied Mathematics, National Dong Hwa University, Hualien, Taiwan.
- National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan.
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States.
- Taiwan Lung Cancer Tissue/Specimen Information Resource Center, National Health Research Institutes, Zhunan, Taiwan.
ORCID-Profile: Tzu-Yu Chen, Shih Sheng Jiang, Jiyeon Choi, Hsiao-Han Hung, Jianxin Shi, Batel Blechter, Charles E Breeze, Gee-Chen Chang, Ying-Huang Tsai, Wu-Chou Su, Ming-Shyan Huang, Yuh-Min Chen, Yueh-Feng Wen, Chih-Liang Wang, Fang-Yu Tsai, Lu-Hai Wang, Pan-Chyr Yang, Chih-Yi Chen, Stephen J Chanock, I-Shou Chang, Chao A Hsiung
Förderung
- Ministry of Health and Welfare grants
- National Health Research Institutes
- Ministry of Science and Technology
- National Science and Technology Council
Zitieren
APA
Chen, T. Y., Chien, L. H., Jiang, S. S., Choi, J., Hung, H. H., Hsiao, C. F., Shi, J., Blechter, B., Breeze, C. E., Chang, G. C., Chen, K. Y., Tsai, Y. H., Su, W. C., Huang, M. S., Chen, Y. M., Wen, Y. F., Chen, C. Y., Wang, C. L., Tsai, F. Y., …, & Hsiung, C. A. (2026). Identifying expression and DNA methylation biomarkers for lung adenocarcinoma risk in East Asia. JNCI: Journal of the National Cancer Institute, 118(6), 1032-1045. https://doi.org/10.1093/jnci/djag021
Vancouver
Chen TY, Chien LH, Jiang SS, Choi J, Hung HH, Hsiao CF, et al. Identifying expression and DNA methylation biomarkers for lung adenocarcinoma risk in East Asia. JNCI: Journal of the National Cancer Institute. 2026;118(6):1032-1045. doi:10.1093/jnci/djag021
BibTeX
@article{Chen2026,
author = {Chen, Tzu-Yu and Chien, Li-Hsin and Jiang, Shih Sheng and Choi, Jiyeon and Hung, Hsiao-Han and Hsiao, Chin-Fu and Shi, Jianxin and Blechter, Batel and Breeze, Charles E and Chang, Gee-Chen and Chen, Kuan-Yu and Tsai, Ying-Huang and Su, Wu-Chou and Huang, Ming-Shyan and Chen, Yuh-Min and Wen, Yueh-Feng and Chen, Chung-Yu and Wang, Chih-Liang and Tsai, Fang-Yu and Chen, Hui-Ling and Hsieh, Wan-Shan and Lin, Hsien-Chih and Wang, Lu-Hai and Chen, Chien-Jen and Yang, Pan-Chyr and Chen, Chih-Yi and Rothman, Nathaniel and Chanock, Stephen J and Lan, Qing and Chang, I-Shou and Hsiung, Chao A},
title = {Identifying expression and DNA methylation biomarkers for lung adenocarcinoma risk in East Asia},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2026},
volume = {118},
number = {6},
pages = {1032--1045},
doi = {10.1093/jnci/djag021}
}
EUVIMED